Review
Copyright ©2010 Baishideng Publishing Group Co.
World J Cardiol. Apr 26, 2010; 2(4): 78-88
Published online Apr 26, 2010. doi: 10.4330/wjc.v2.i4.78
Table 3 Comparison of drug-eluting stents to coronary artery bypass surgery for unprotected left main coronary artery stenosis
Chieffo et al[7]Lee et al[9]Palmerini et al[15]Buszman et al[17]Seung et al[21]
Study designRegistryRegistryRegistryRandomized studyRegistry
Treatment typePCI with SES, PESCABGPCI with SESCABGPCI with SESCABGPCI with BMS, DESCABGPCI with BMS, DESCABG
No. of patient10714250123157154525311021138
Age (yr)6468727073a6961616264
Ejection fraction (%)52525152525554546260
EuroSCORE or Parsonnet score (Lee)4.44.318.0a13.06.0a5.03.33.5NANA
Initial clinical outcomesIn-hospital30 d30 d30 dNA
Death (%)0.02.02.05.03.24.50.00.0NANA
Myocardial infarction (%)9.026.00.02.04.51.91.93.8NANA
TVR (%)0.02.00.01.00.60.61.90.0NANA
Any MACE (%)NANA0.08.0NANANANANANA
Cerebrovascular accident0.01.42.0a17.0NANA0.02.0NANA
Long-term clinical outcomesCumulative after dischargeKaplan-MeierCumulativeAt 1 yrKaplan-Meier at 3 yr for propensity-matched cohort
Mean follow-up (mo)12.012.06.06.014.014.0NANA33.938.4
Death (%)2.86.44.013.013.412.31.97.57.97.8
Myocardial infarction (%)0.91.4NANA8.34.51.95.7NANA
TVR (%)19.6a3.67.01.025.5a2.628.8a9.412.62.6
Cerebrovascular accident (%)0.90.7NANANANA0.03.8NANA
Any events (%)NANA11.017.0NANANANANANA